ÂÜÀòÂÒÂ×

Victor Facchini is a finance professional with extensive experience in financial planning and analysis across various sectors, including pharmaceutical and biotechnology industries. As the Director of FP&A at Cybrexa Therapeutics since April 2023, Victor is involved in developing innovative cancer treatments. Prior roles include FP&A Manager at Nelson Laboratories, where Victor drove improvements in financial processes, and Senior Project Accountant at Ironstate Development Company, managing a $650MM portfolio. Victor's career also includes significant positions at Merck and Organon, where financial leadership spanned global drug development, strategic planning, and compliance. Victor holds a Bachelor of Commerce in Finance, Economics, and Management from York University, along with an Accounting Diploma from Seneca Polytechnic.